Welcome to our dedicated page for Blackrock SEC filings (Ticker: BLK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for BlackRock, Inc. (NYSE: BLK), a global asset manager and financial technology provider classified in the finance and insurance sector under investment banking and securities dealing. These filings offer detailed information about BlackRock’s financial results, corporate actions, securities listings, and other material events.
Recent Form 8-K filings show how BlackRock reports quarterly and annual earnings. For example, filings dated January 15, 2026, October 14, 2025, and July 15, 2025 state that the company reported results of operations for specific periods and furnished earnings releases and supplemental materials as exhibits. They also note investor conference calls and webcasts where management discusses these results. Investors can review these documents to understand revenue drivers, expenses, and other aspects of BlackRock’s financial condition as disclosed in the attached materials.
Filings also document corporate transactions and capital structure details. A Form 8-K filed on July 1, 2025 describes the completion of BlackRock’s acquisition of 100% of the business and assets of HPS Investment Partners, characterized as a leading global credit investment manager. The filing explains the issuance of units in a BlackRock subsidiary that are exchangeable into BlackRock common stock, as well as restricted stock units and potential contingent consideration tied to post-closing performance. Another filing lists BlackRock’s securities registered under Section 12(b) of the Exchange Act, including its common stock (BLK) and 3.750% Notes due 2035 (BLK 35), both traded on the New York Stock Exchange.
Through this filings page, users can follow ongoing disclosure related to BlackRock’s operations, acquisitions, financing arrangements, and governance matters as reported to the U.S. Securities and Exchange Commission. Stock Titan enhances this information by pairing real-time updates from EDGAR with AI-powered summaries that help explain the structure and implications of filings such as 8-Ks, annual reports on Form 10-K, quarterly reports on Form 10-Q, and insider transaction reports on Form 4, making it easier to interpret complex regulatory documents.
BlackRock, Inc. filed an amended Schedule 13G reporting beneficial ownership of 5,419,901 shares of Vital Farms, Inc. common stock, representing 12.1% of the class as of 12/31/2025. BlackRock reports sole power to vote or direct the vote over 5,351,241 shares and sole power to dispose or direct the disposition of 5,419,901 shares, with no shared voting or dispositive power. The filing notes that various underlying persons have rights to dividends or sale proceeds, but no individual person has more than five percent of the total outstanding common shares. BlackRock states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Vital Farms.
BlackRock, Inc. filed Amendment No. 10 to report its beneficial ownership of 1,067,363 shares of MGP INGREDIENTS INC common stock, representing 5.01% of the class as of 12/31/2025. BlackRock reports sole power to vote 1,034,539 shares and sole power to dispose of 1,067,363 shares, with no shared voting or dispositive power.
The filing states that various persons have the right to receive dividends or sale proceeds from these shares, but no single person has more than five percent of the total outstanding common shares. BlackRock certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of MGP Ingredients.
BlackRock, Inc. filed an amended Schedule 13G reporting its beneficial ownership of LKQ Corporation common stock as of 12/31/2025. BlackRock reports beneficial ownership of 29,234,280 shares, representing 11.4% of LKQ’s common stock. It has sole power to vote 28,434,917 shares and sole power to dispose of 29,234,280 shares, with no shared voting or dispositive power.
The filing explains that these holdings reflect securities owned or deemed owned by certain BlackRock business units. It also notes that iShares Core S&P Small-Cap ETF has an interest in LKQ common stock of more than five percent of the total outstanding common stock. BlackRock certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of LKQ.
BlackRock, Inc. reports beneficial ownership of 1,607,055 common shares of Helen of Troy Limited, representing 7.0% of the company’s common stock. BlackRock has sole voting power over 1,567,065 shares and sole dispositive power over 1,607,055 shares, with no shared voting or dispositive power. The filing notes that various persons have rights to receive dividends or sale proceeds from these shares, but no single person has more than five percent of the total outstanding common shares. BlackRock states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Helen of Troy.
BlackRock, Inc. has filed an amended Schedule 13G reporting beneficial ownership of 17,806,183 shares of INDIVIOR PLC common stock, representing 14.3% of the outstanding class as of the event date. BlackRock reports sole power to vote 17,585,684 shares and sole power to dispose of 17,806,183 shares, with no shared voting or dispositive power.
The filing is made on a passive basis under Schedule 13G, with BlackRock certifying that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Indivior. The filing notes that one investor, iShares Core S&P Small-Cap ETF, has an interest in more than five percent of Indivior’s outstanding common stock.
BlackRock, Inc. reported an equity award to one of its directors. On December 31, 2025, a nonemployee director received 33 shares of BlackRock common stock, with a par value of $0.01 per share. The award was granted under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan and was valued for grant purposes at $1,070.34 per share, which was the closing stock price on that date.
After this stock grant, the reporting person beneficially owns 1,862 shares of BlackRock common stock, held in direct ownership. The transaction is reported as an acquisition of shares at a price of $0, reflecting that it was an equity compensation grant rather than a market purchase.
BlackRock, Inc. director Charles H. Robbins reported a stock grant of 27 common shares. The Form 4 shows that on December 31, 2025, he acquired 27 shares of BlackRock common stock at a price of $0, reflecting an award rather than a purchase. After this grant, he beneficially owned 2,847 BlackRock shares in direct ownership form.
The shares were granted to him as a nonemployee director under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, with the award value based on a share price of $1,070.34, which was the stock’s closing price on December 31, 2025.
BlackRock, Inc. reported an equity award to one of its directors. On December 31, 2025, a nonemployee director received 30 shares of BlackRock common stock as an award under the company’s stock award and incentive plan. The transaction is recorded at a price of $0 per share because it is a grant, not a market purchase, and is valued based on the stock’s closing price of $1,070.34 on that date. Following this award, the director beneficially owns 1,780 shares of BlackRock common stock, held directly.
BlackRock, Inc. director Gordon Nixon reported receiving a grant of common stock as a nonemployee director. On 12/31/2025, he was awarded 34 shares of BlackRock common stock under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan.
The grant was based on a reference price of $1,070.34 per share, which was the closing price on December 31, 2025. Following this award, Nixon beneficially owns 5,309 shares of BlackRock common stock in direct ownership.
BlackRock, Inc. director equity filing: A BlackRock nonemployee director reported receiving a grant of 27 shares of BlackRock common stock on 12/31/2025 under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan. The award was recorded at a reference value of $1,070.34 per share, which was the stock’s closing price on that date, and the director did not pay cash for the shares. Following this grant, the director beneficially owns 844 BlackRock common shares directly and 142 shares indirectly through a family trust, showing both personal and trust-based ownership positions in the company.